医療シミュレーション市場 : 2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2024年1月

Healthcare Simulation Market – Global Forecast to 2028

医療シミュレーション市場 : 提供内容 [シミュレーション (患者の忠実度、外科手術 – 腹腔鏡、CVD、整形外科、脊椎、婦人科、超音波)、トレーニングサービス]、テクノロジー (3D プリンティング、仮想患者、手術リハーサル)、エンド ユーザーと地域別 – 2028年までの世界予測
Healthcare Simulation Market by Offering (Simulation (Patient -Fidelity, Surgical – Laparoscopic, CVD, Ortho, Spine, Gynae, Ultrasound), Training Services), Technology (3D printing, virtual patient, procedural rehearsal), End User & Region – Global Forecast to 2028

ページ数359
図表数340
種別英文調査報告書
価格

お問合せ・ご注文  価格・納期について

Report Overview

The global healthcare simulation market is projected to reach USD 5.2 billion by 2028 from USD 2.3 billion in 2023, at a high CAGR of 16.7% during the forecast period.

世界の医療シミュレーション市場は、2023年の23億米ドルから2028年までに52億米ドルに達すると予測されており、予測期間中に16.7%という高いCAGRで成長します。

The market’s expansion is fueled by an increasing emphasis on patient safety and a preference for virtual interaction. Nevertheless, challenges such as a shortage of skilled healthcare professionals and the high cost of simulators are anticipated to somewhat impede the market’s growth.

医療シミュレーション市場 : 2028年までの世界予測


“The segment of web-based simulation demonstrated the most substantial growth in the healthcare simulation market, by product & service.”
In terms of product & service, the web-based simulation segment experienced the most significant growth in the healthcare simulation market throughout the forecast period. The expansion of this segment can be attributed to the widespread availability of internet services and the increasing government initiatives to adopt Healthcare Information Technology (HCIT) solutions.

“The largest segment in the healthcare simulation market by the end user was academic institutes in the year 2022.”
The academic institutes segment is anticipated to experience the highest growth rate in the healthcare simulation market in 2022. The rising use of simulation models in medical surgeries, a heightened emphasis on error reduction, and the cost-effectiveness of procedural training for medical physicians are expected to fuel the demand for healthcare simulation services in the upcoming years.

医療シミュレーション市場 : 2028年までの世界予測 ecosystem


“APAC region is expected to experience the most substantial growth rate throughout the forecast period.”
The Asia-Pacific region is experiencing the highest growth rate in the healthcare simulation market due to several factors such as there is a rising awareness of the importance of advanced medical training and patient safety in healthcare across the region, increasing investments in healthcare infrastructure and education contribute to the adoption of simulation technologies and the growing demand for skilled healthcare professionals, coupled with advancements in technology, fuels the need for innovative training methods. The combination of these factors positions the region as a dynamic and rapidly expanding market for healthcare simulation solutions.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
• By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

医療シミュレーション市場 : 2028年までの世界予測 region


Key Players in the Healthcare Simulation Market
The key players functioning in the healthcare simulation market include CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK), Kyoto Kagaku (Japan), Mentice AB (Sweden), Gaumard Scientific Co. (US), Operative Experience Inc. (US), Cardionics Inc. (US) (a subsidiary of 3B Scientific), VirtaMed AG (Switzerland), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), Simendo B.V. (Netherlands) VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), Inovus Medical (UK), TruCorp Ltd. (Ireland), and Surgical Science Sweden AG (Sweden). 


Research Coverage:
The report analyses the healthcare simulation market. It aims to estimate the market size and future growth potential of various market segments based on product & service, end-user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will enrich established firms and new entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.


This report provides insights on:
n Analysis of key drivers: (Limited access to patients during medical training, Rising technological advancements in medical education), restraints (Increasing focus on patient safety, Growing preference for virtual interaction), opportunities (Growing awareness about simulation training in emerging economies), and challenges (High cost of simulators, Operational challenges) influencing the growth of the healthcare simulation market.
n Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the healthcare simulation market.
n Market Development: Comprehensive information on the lucrative emerging markets, products & services, end-users, and regions.
n Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the healthcare simulation market.
n Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the healthcare simulation market like CAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK).

Table of Contents

1            INTRODUCTION            40

1.1         STUDY OBJECTIVES      40

1.2         MARKET DEFINITION AND SCOPE         40

1.2.1      INCLUSIONS AND EXCLUSIONS 40

1.2.2      MARKET SCOPE             41

FIGURE 1           HEALTHCARE SIMULATION MARKET SEGMENTATION 41

1.2.3      REGIONAL SCOPE         42

1.2.4      YEARS CONSIDERED     42

1.3         CURRENCY CONSIDERED          43

1.4         UNITS CONSIDERED     43

TABLE 1             EXCHANGE RATES CONSIDERED FOR CONVERSION TO USD              43

1.5         STAKEHOLDERS            43

1.6         SUMMARY OF CHANGES            44

1.7         RECESSION IMPACT      44

2            RESEARCH METHODOLOGY     45

2.1         RESEARCH APPROACH 45

2.2         HEALTHCARE SIMULATION MARKET: RESEARCH DESIGN         45

2.2.1      SECONDARY RESEARCH             46

2.2.1.1   Key data from secondary sources     47

2.2.2      PRIMARY DATA 47

FIGURE 2           PRIMARY SOURCES       47

2.2.2.1   Key data from primary sources         48

2.2.2.2   Insights from primary experts          49

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY,  DESIGNATION, AND REGION    49

2.3         MARKET SIZE ESTIMATION: HEALTHCARE SIMULATION MARKET              50

FIGURE 4           ESTIMATION OF MARKET SIZE FOR HEALTHCARE SIMULATION ACADEMIC INSTITUTES AND HOSPITALS THROUGH DEMAND-SIDE APPROACH            50

FIGURE 5           ESTIMATION OF GLOBAL HEALTHCARE SIMULATION MARKET SIZE THROUGH DEMAND-SIDE APPROACH    51

FIGURE 6           SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS          51

FIGURE 7           BOTTOM-UP APPROACH: SEGMENTAL EXTRAPOLATION              52

FIGURE 8           CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       53

FIGURE 9           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   54

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    55

FIGURE 10         DATA TRIANGULATION             55

2.5         MARKET SHARE ESTIMATION   56

2.6         RESEARCH ASSUMPTIONS         56

2.7         RESEARCH LIMITATIONS           57

2.7.1      METHODOLOGY-RELATED LIMITATIONS         57

2.7.2      SCOPE-RELATED LIMITATIONS             57

2.8         RISK ASSESSMENT         57

TABLE 2             RISK ASSESSMENT: HEALTHCARE SIMULATION MARKET              57

2.9         RECESSION IMPACT ANALYSIS 57

3            EXECUTIVE SUMMARY 58

FIGURE 11        HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2023 VS. 2028 (USD MILLION)     58

FIGURE 12         HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2023 VS. 2028  (USD MILLION)          59

FIGURE 13         HEALTHCARE SIMULATION MARKET, BY END USER, 2023 VS. 2028  (USD MILLION)   60

FIGURE 14         HEALTHCARE SIMULATION MARKET: REGIONAL SNAPSHOT              61

4            PREMIUM INSIGHTS      62

4.1         ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE SIMULATION MARKET 62

FIGURE 15         ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO DRIVE NORTH AMERICAN MARKET GROWTH 62

4.2         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET,  BY PRODUCT & SERVICE AND COUNTRY            63

FIGURE 16         HEALTHCARE SIMULATION ANATOMICAL MODELS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC    63

4.3         HEALTHCARE SIMULATION MARKET: REGIONAL GROWTH OPPORTUNITIES           64

FIGURE 17         CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD              64

4.4         REGIONAL MIX: HEALTHCARE SIMULATION MARKET  65

FIGURE 18         NORTH AMERICA TO LEAD HEALTHCARE SIMULATION MARKET DURING FORECAST PERIOD   65

4.5         HEALTHCARE SIMULATION MARKET: EMERGING VS.  DEVELOPED ECONOMIES     66

FIGURE 19         EMERGING COUNTRIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD     66

5            MARKET OVERVIEW     67

5.1         INTRODUCTION            67

5.2         MARKET DYNAMICS     67

FIGURE 20         HEALTHCARE SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    67

5.3         MARKET DYNAMICS: IMPACT ANALYSIS             68

5.3.1      DRIVERS            68

5.3.1.1   Limited access to patients during medical training       68

5.3.1.2   Rising technological advancements in medical education           69

5.3.1.3   Growing demand for minimally invasive treatments     69

FIGURE 21         TOP MINIMALLY INVASIVE COSMETIC PROCEDURES PERFORMED IN 2022     70

5.3.1.4   Increasing focus on patient safety    70

5.3.1.5   Growing preference for virtual interaction     71

5.3.2      RESTRAINTS     71

5.3.2.1   Limited availability of funds             71

5.3.2.2   Poorly designed medical simulators 71

5.3.3      OPPORTUNITIES           72

5.3.3.1   Shortage of healthcare personnel     72

5.3.3.2   Growing awareness about simulation training in emerging economies     72

5.3.4      CHALLENGES   73

5.3.4.1   High cost of simulators      73

5.3.4.2   Operational challenges      73

5.4         INDUSTRY TRENDS       74

5.4.1      USE OF VIRTUAL REALITY AND AUGMENTED REALITY IN HEALTHCARE SIMULATION      74

5.4.2      HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS    74

5.4.3      MULTIMODAL APPROACH IN DEVELOPMENT OF SIMULATORS              75

5.4.4      UTILIZATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE IN SURGICAL PROCEDURES       75

5.4.5      GROWING USE OF HCIT/EMR   76

5.5         TECHNOLOGY ANALYSIS           76

5.5.1      INTEGRATION OF ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY              77

5.6         ECOSYSTEM ANALYSIS 77

FIGURE 22         HEALTHCARE SIMULATION MARKET: ECOSYSTEM       77

5.7         VALUE CHAIN ANALYSIS            78

FIGURE 23         HEALTHCARE SIMULATION MARKET: VALUE CHAIN ANALYSIS              79

5.8         PORTER’S FIVE FORCES ANALYSIS         79

TABLE 3             HEALTHCARE SIMULATION MARKET: PORTER’S FIVE FORCES ANALYSIS          79

5.8.1      THREAT OF NEW ENTRANTS    80

5.8.2      THREAT OF SUBSTITUTES         80

5.8.3      BARGAINING POWER OF SUPPLIERS     80

5.8.4      BARGAINING POWER OF BUYERS           80

5.8.5      INTENSITY OF COMPETITIVE RIVALRY 81

5.9         PATENT ANALYSIS        81

5.9.1      PATENT PUBLICATION TRENDS FOR HEALTHCARE SIMULATION MARKET            81

FIGURE 24         PATENT PUBLICATION TRENDS (2013–2023)     81

5.9.2      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS        82

FIGURE 25         TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) OF HEALTHCARE SIMULATION PATENTS (JANUARY 2013–DECEMBER 2023)              82

FIGURE 26         TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE SIMULATION PATENTS (JANUARY 2013–DECEMBER 2023)          83

5.9.3      LIST OF MAJOR PATENTS          83

TABLE 4             KEY PATENTS IN HEALTHCARE SIMULATION MARKET 83

5.10       TARIFF AND REGULATORY LANDSCAPE            85

5.10.1    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          85

TABLE 5             NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         85

TABLE 6             EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86

TABLE 7             ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         87

TABLE 8             HEALTHCARE SIMULATION MARKET: REGULATORY STANDARDS     88

5.10.2    HEALTHCARE SIMULATION PRODUCTS            88

5.10.2.1 North America     88

5.10.2.1.1            US         88

TABLE 9             CLASSIFICATION OF MEDICAL DEVICES BY US FDA       89

5.10.2.1.2            Canada  89

5.10.2.2 Europe  89

5.10.2.3 Asia Pacific          89

5.10.2.3.1            Japan     89

TABLE 10           CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 90

5.10.2.3.2            China     90

TABLE 11           NMPA MEDICAL DEVICE CLASSIFICATION         90

5.10.2.3.3            India      91

5.10.3    INTEROPERABILITY STANDARDS          91

TABLE 12           KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM     91

TABLE 13           QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM  94

5.11       PRICING ANALYSIS        94

5.11.1    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT              94

FIGURE 27         AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT         94

TABLE 14           AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT         95

5.11.2    REGIONAL PRICING ANALYSIS OF MEDICAL SIMULATORS         95

5.12       HEALTHCARE SIMULATION MARKET INVESTMENT LANDSCAPE              95

FIGURE 28         HEALTHCARE SIMULATION FUNDING IN 2022  95

FIGURE 29         MOST VALUED HEALTHCARE SIMULATION FIRMS IN 2022 (USD BILLION) 96

5.13       KEY CONFERENCES AND EVENTS (Q4 2023–Q3 2024)      96

5.14       TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS       97

FIGURE 30         REVENUE SHIFT IN HEALTHCARE SIMULATION MARKET              97

5.15       KEY STAKEHOLDERS & BUYING CRITERIA          98

5.15.1    KEY STAKEHOLDERS IN BUYING PROCESS         98

FIGURE 31         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP  THREE END USERS           98

TABLE 15           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS             98

5.15.2    BUYING CRITERIA         99

FIGURE 32         KEY BUYING CRITERIA FOR TOP THREE END USERS      99

TABLE 16           KEY BUYING CRITERIA FOR TOP THREE END USERS      99

5.16       CASE STUDY ANALYSIS 100

5.16.1    CASE STUDY 1  100

5.16.2    CASE STUDY 2  101

5.17       UNMET NEEDS 101

TABLE 17           UNMET NEEDS IN HEALTHCARE SIMULATION MARKET              101

5.17.1    END USER EXPECTATIONS        102

TABLE 18           END USER EXPECTATIONS IN HEALTHCARE SIMULATION MARKET            102

6            HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE 104

6.1         INTRODUCTION            105

TABLE 19          HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)          105

6.2         HEALTHCARE SIMULATION ANATOMICAL MODELS     105

TABLE 20           HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE,  2021–2028 (USD MILLION)    106

TABLE 21           HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         107

6.2.1      PATIENT SIMULATORS 107

TABLE 22           KEY PLAYERS OFFERING PATIENT SIMULATORS            108

TABLE 23           PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          110

TABLE 24           PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110

TABLE 25           PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 111

6.2.1.1   By type  111

6.2.1.1.1 High-fidelity simulators     111

6.2.1.1.1.1           Growing adoption of high-fidelity simulators in educational training to drive growth        111

TABLE 26           KEY MARKET PLAYERS OFFERING HIGH-FIDELITY SIMULATORS    112

TABLE 27           HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    112

6.2.1.1.2 Medium-fidelity simulators 113

6.2.1.1.2.1           Cost benefits of medium-fidelity simulation to drive demand     113

TABLE 28           KEY MARKET PLAYERS OFFERING MEDIUM-FIDELITY SIMULATORS    113

TABLE 29           MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 114

6.2.1.1.3 Low-fidelity simulators      114

6.2.1.1.3.1           Budgetary constraints and ease of use to drive demand 114

TABLE 30           KEY MARKET PLAYERS OFFERING LOW-FIDELITY SIMULATORS    115

TABLE 31          LOW-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          116

6.2.1.2   By application      116

6.2.1.2.1 Laparoscopic surgical simulators      116

6.2.1.2.1.1           Increasing prevalence of minimally invasive surgeries to drive growth              116

TABLE 32           LAPAROSCOPIC SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         117

6.2.1.2.2 Gynecology simulators       117

6.2.1.2.2.1           Increasing incidence of fibroids and polyps in women to drive demand              117

TABLE 33           GYNECOLOGY PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          118

6.2.1.2.3 Cardiovascular simulators  118

6.2.1.2.3.1           Increasing prevalence of diabetes to boost demand      118

TABLE 34           CARDIOVASCULAR PATIENT SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 119

6.2.1.2.4 Orthopedic surgical simulators        119

6.2.1.2.4.1           Enhancement in surgeon skills by orthopedic simulation training to drive demand 119

TABLE 35           ORTHOPEDIC SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 120

6.2.1.2.5 Spine surgical simulators   120

6.2.1.2.5.1           Mastering spine surgeries through advanced simulation techniques to boost demand      120

TABLE 36           SPINE SURGICAL PATIENT SIMULATORS MARKET, BY COUNTRY, 2021–2028  (USD MILLION) 121

6.2.1.2.6 Endovascular simulators    121

6.2.1.2.6.1           Reduced mortality rates associated with endovascular simulators to boost demand 121

TABLE 37           ENDOVASCULAR PATIENT SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 122

6.2.1.2.7 Other applications in patient simulators         122

TABLE 38           PATIENT SIMULATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,  2021–2028 (USD MILLION)         123

6.2.2      TASK TRAINERS             123

6.2.2.1   Inability to imitate emotional attributes of patients to restrain growth      123

TABLE 39           KEY MARKET PLAYERS OFFERING TASK TRAINERS        124

TABLE 40           TASK TRAINERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          125

6.2.3      INTERVENTIONAL/SURGICAL SIMULATORS     125

TABLE 41           INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 126

TABLE 42          INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          127

6.2.3.1   Laparoscopic surgical simulators      127

6.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth     127

TABLE 43           KEY MARKET PLAYERS OFFERING LAPAROSCOPIC SURGICAL SIMULATORS    128

TABLE 44           LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 128

6.2.3.2   Gynecology simulators       129

6.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators        129

TABLE 45           KEY MARKET PLAYERS OFFERING GYNECOLOGY SIMULATORS    129

TABLE 46           GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     130

6.2.3.3   Cardiovascular simulators  130

6.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand  130

TABLE 47           KEY MARKET PLAYERS OFFERING CARDIOVASCULAR SIMULATORS    131

TABLE 48           CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          131

6.2.3.4   Orthopedic surgical simulators        132

6.2.3.4.1 Enhancement in surgeon skills by orthopedic simulation training to drive demand              132

TABLE 49           KEY MARKET PLAYERS OFFERING ORTHOPEDIC SIMULATORS              132

TABLE 50          ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)          133

6.2.3.5   Spine surgical simulators   133

6.2.3.5.1 Mastering spine surgeries through advanced simulation techniques to boost demand 133

TABLE 51           KEY MARKET PLAYERS OFFERING SPINE SURGICAL SIMULATORS    134

TABLE 52           SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     134

6.2.3.6   Endovascular simulators    135

6.2.3.6.1 Ability to reduce mortality rates to drive demand for endovascular simulators              135

TABLE 53           KEY MARKET PLAYERS OFFERING ENDOVASCULAR SIMULATORS    135

TABLE 54           ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     136

6.2.3.7   Other surgical simulators   136

TABLE 55           KEY MARKET PLAYERS OFFERING OTHER SURGICAL SIMULATORS    137

TABLE 56           OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     137

6.2.4      ULTRASOUND SIMULATORS     138

6.2.4.1   Inferior quality images due to low dynamics and spatial resolution to restrain growth   138

TABLE 57           KEY MARKET PLAYERS OFFERING ULTRASOUND SIMULATORS              138

TABLE 58           ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     139

6.2.5      DENTAL SIMULATORS 140

6.2.5.1   Expanding dental tourism industry to drive growth      140

TABLE 59           KEY PLAYERS OFFERING DENTAL SIMULATORS             140

TABLE 60           DENTAL SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          141

6.2.6      EYE SIMULATORS          141

6.2.6.1   Increasing incidence of eye disorders to drive growth   141

TABLE 61           KEY PLAYERS OFFERING EYE SIMULATORS       142

TABLE 62           EYE SIMULATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          142

6.3         WEB-BASED SIMULATION         143

6.3.1      RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF WEB-BASED SIMULATION         143

TABLE 63           KEY PLAYERS OFFERING WEB-BASED SIMULATORS       143

TABLE 64           WEB-BASED SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 144

6.4         HEALTHCARE SIMULATION SOFTWARE             144

6.4.1      KEY ADVANTAGES OFFERED BY HEALTHCARE SIMULATION SOFTWARE TO DRIVE ADOPTION          144

TABLE 65           KEY MARKET PLAYERS OFFERING HEALTHCARE SIMULATION SOFTWARE       145

TABLE 66           HEALTHCARE SIMULATION SOFTWARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 146

6.5         HEALTHCARE SIMULATION TRAINING SERVICES           146

TABLE 67           HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)          147

TABLE 68           HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    147

6.5.1      VENDOR-BASED TRAINING       148

6.5.1.1   High focus on patient safety to drive demand 148

TABLE 69           KEY MARKET PLAYERS OFFERING VENDOR-BASED TRAINING SERVICES          148

TABLE 70           VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY,  2021–2028 (USD MILLION)          149

6.5.2      EDUCATIONAL SOCIETIES        149

6.5.2.1   Growing need for proper training and authenticity of knowledge to drive growth              149

TABLE 71           KEY PLAYERS OFFERING EDUCATIONAL SOCIETIES SIMULATORS    150

TABLE 72           EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150

6.5.3      CUSTOM CONSULTING SERVICES          151

6.5.3.1   Growing need to limit errors associated with traditional medical training systems to drive growth    151

TABLE 73           KEY MARKET PLAYERS OFFERING CUSTOM CONSULTING SERVICES          151

TABLE 74           CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          152

7            HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY            153

7.1         INTRODUCTION            154

TABLE 75           HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)     154

7.2         VIRTUAL PATIENT SIMULATION            154

7.2.1      INCREASING FOCUS ON AUGMENTED REALITY/VIRTUAL REALITY TO DRIVE MARKET 154

TABLE 76           VIRTUAL PATIENT SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     155

7.3         3D PRINTING    155

7.3.1      INCREASING ADOPTION IN MEDICAL TRAINING TO DRIVE MARKET              155

TABLE 77           3D PRINTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          156

7.4         PROCEDURAL REHEARSAL TECHNOLOGY         156

7.4.1      IMPROVING SURGICAL SKILLS WITH PROCEDURAL REHEARSAL TECHNOLOGY TO DRIVE MARKET        156

TABLE 78           PROCEDURAL REHEARSAL TECHNOLOGY MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 157

8            HEALTHCARE SIMULATION MARKET, BY END USER      158

8.1         INTRODUCTION            159

TABLE 79           HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION) 159

8.2         ACADEMIC INSTITUTES             159

8.2.1      GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND           159

TABLE 80           HEALTHCARE SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY,  2021–2028 (USD MILLION) 160

8.3         HOSPITALS       160

8.3.1      RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND              160

TABLE 81           HEALTHCARE SIMULATION MARKET FOR HOSPITALS, BY COUNTRY,  2021–2028 (USD MILLION) 161

8.4         MILITARY ORGANIZATIONS      162

8.4.1      EXPLORATION OF NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND  162

TABLE 82           HEALTHCARE SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY,  2021–2028 (USD MILLION)    163

8.5         OTHER END USERS        163

TABLE 83           HEALTHCARE SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY,  2021–2028 (USD MILLION)         164

9            HEALTHCARE SIMULATION MARKET, BY REGION          165

9.1         INTRODUCTION            166

TABLE 84           HEALTHCARE SIMULATION MARKET, BY REGION, 2021–2028 (USD MILLION) 166

9.2         NORTH AMERICA          166

FIGURE 33         NORTH AMERICA: HEALTHCARE SIMULATION MARKET SNAPSHOT (2022)          167

TABLE 85           NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 168

TABLE 86           NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         168

TABLE 87           NORTH AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION)            168

TABLE 88           NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          169

TABLE 89           NORTH AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        169

TABLE 90           NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    170

TABLE 91           NORTH AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)           170

TABLE 92           NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       171

TABLE 93           NORTH AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION) 171

9.2.1      NORTH AMERICA: RECESSION IMPACT ANALYSIS          171

9.2.2      US         172

9.2.2.1   Increasing demand for virtual tutors and high healthcare spending to boost growth              172

TABLE 94           US: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    172

TABLE 95           US: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 173

TABLE 96           US: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          173

TABLE 97           US: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     173

TABLE 98           US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          174

TABLE 99           US: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)    174

TABLE 100         US: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)          175

TABLE 101         US: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)     175

9.2.3      CANADA            175

9.2.3.1   Increasing funding and surgical capabilities to drive growth       175

TABLE 102         CANADA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION) 176

TABLE 103         CANADA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 176

TABLE 104         CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 177

TABLE 105         CANADA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          177

TABLE 106         CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 178

TABLE 107         CANADA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 178

TABLE 108         CANADA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       179

TABLE 109         CANADA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          179

9.3         EUROPE             179

TABLE 110         EUROPE: HEALTHCARE SIMULATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 111         EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION) 181

TABLE 112         EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 181

TABLE 113         EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 181

TABLE 114         EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          182

TABLE 115         EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 182

TABLE 116         EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 183

TABLE 117         EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       183

TABLE 118         EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          183

9.3.1      EUROPE: RECESSION IMPACT ANALYSIS            184

9.3.2      UK         184

9.3.2.1   Rising number of healthcare simulation centers and hospitals to drive growth              184

TABLE 119         UK: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    185

TABLE 120         UK: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 185

TABLE 121         UK: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          185

TABLE 122         UK: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     186

TABLE 123         UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          186

TABLE 124         UK: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)    187

TABLE 125         UK: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)          187

TABLE 126         UK: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)     187

9.3.3      FRANCE             188

9.3.3.1   Growing focus on use of innovative methods in medical training to drive growth              188

TABLE 127         FRANCE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION) 188

TABLE 128         FRANCE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 189

TABLE 129         FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 189

TABLE 130         FRANCE: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          190

TABLE 131        FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    190

TABLE 132         FRANCE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 191

TABLE 133         FRANCE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       191

TABLE 134         FRANCE: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          191

9.3.4      GERMANY         192

9.3.4.1   High healthcare spending to drive growth      192

TABLE 135         GERMANY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         192

TABLE 136         GERMANY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION)            193

TABLE 137         GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     193

TABLE 138         GERMANY: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          194

TABLE 139         GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 194

TABLE 140         GERMANY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 195

TABLE 141         GERMANY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       195

TABLE 142         GERMANY: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION)          195

9.3.5      ITALY   196

9.3.5.1   Shortage of trained healthcare personnel to drive growth           196

TABLE 143         ITALY: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    196

TABLE 144         ITALY: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 197

TABLE 145         ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 197

TABLE 146         ITALY: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          198

TABLE 147         ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    198

TABLE 148         ITALY: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 199

TABLE 149         ITALY: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)          199

TABLE 150         ITALY: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          199

9.3.6      SPAIN   200

9.3.6.1   Increasing number of surgical procedures to boost growth         200

TABLE 151         SPAIN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    200

TABLE 152         SPAIN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 201

TABLE 153         SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 201

TABLE 154         SPAIN: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          202

TABLE 155         SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    202

TABLE 156         SPAIN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 203

TABLE 157         SPAIN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       203

TABLE 158         SPAIN: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          203

9.3.7      REST OF EUROPE           204

TABLE 159         REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         204

TABLE 160         REST OF EUROPE: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION)            205

TABLE 161         REST OF EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          205

TABLE 162         REST OF EUROPE: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        206

TABLE 163         REST OF EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 206

TABLE 164         REST OF EUROPE: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)           207

TABLE 165         REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       207

TABLE 166         REST OF EUROPE: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION) 207

9.4         ASIA PACIFIC    208

FIGURE 34         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET SNAPSHOT (2022)          209

TABLE 167         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 210

TABLE 168         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         210

TABLE 169         ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION)            211

TABLE 170         ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     211

TABLE 171         ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        212

TABLE 172         ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 212

TABLE 173         ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)           213

TABLE 174         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       213

TABLE 175         ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION)          213

9.4.1      ASIA PACIFIC: RECESSION IMPACT ANALYSIS    214

9.4.2      JAPAN  214

9.4.2.1   Increasing demand for virtual tutors and technologically advanced simulators to drive growth        214

TABLE 176         JAPAN: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    215

TABLE 177         JAPAN: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 215

TABLE 178         JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215

TABLE 179         JAPAN: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          216

TABLE 180         JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    216

TABLE 181         JAPAN: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 217

TABLE 182         JAPAN: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       217

TABLE 183         JAPAN: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          217

9.4.3      CHINA  218

9.4.3.1   Increasing demand for trained medical professionals to drive growth       218

TABLE 184         CHINA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    218

TABLE 185         CHINA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 219

TABLE 186         CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 219

TABLE 187         CHINA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          219

TABLE 188         CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    220

TABLE 189         CHINA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 220

TABLE 190         CHINA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       221

TABLE 191         CHINA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          221

9.4.4      INDIA   221

9.4.4.1   Growing awareness regarding patient safety due to healthcare negligence to drive growth   221

TABLE 192         INDIA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    222

TABLE 193         INDIA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 222

TABLE 194         INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223

TABLE 195         INDIA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          223

TABLE 196         INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    224

TABLE 197         INDIA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 224

TABLE 198         INDIA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)          225

TABLE 199         INDIA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          225

9.4.5      REST OF ASIA PACIFIC  225

TABLE 200         REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    226

TABLE 201         REST OF ASIA PACIFIC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 226

TABLE 202         REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          227

TABLE 203         REST OF ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        227

TABLE 204         REST OF ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,  BY TYPE, 2021–2028 (USD MILLION)    228

TABLE 205         REST OF ASIA PACIFIC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)           228

TABLE 206         REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION) 229

TABLE 207         REST OF ASIA PACIFIC: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION)         229

9.5         LATIN AMERICA             229

TABLE 208         LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 230

TABLE 209         LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)         230

TABLE 210         LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION)            231

TABLE 211         LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          231

TABLE 212         LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        232

TABLE 213         LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 232

TABLE 214         LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION)           233

TABLE 215         LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       233

TABLE 216         LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION) 233

9.5.1      LATIN AMERICA: RECESSION IMPACT ANALYSIS            234

9.5.2      BRAZIL 234

9.5.2.1   High incidence of chronic diseases to drive market      234

TABLE 217         BRAZIL: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    235

TABLE 218         BRAZIL: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 235

TABLE 219         BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235

TABLE 220         BRAZIL: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          236

TABLE 221         BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    236

TABLE 222         BRAZIL: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 237

TABLE 223         BRAZIL: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       237

TABLE 224         BRAZIL: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          237

9.5.3      MEXICO             238

9.5.3.1   Disruptive technologies and public-private partnerships to boost growth 238

TABLE 225         MEXICO: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION) 238

TABLE 226         MEXICO: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 239

TABLE 227         MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 239

TABLE 228         MEXICO: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          240

TABLE 229        MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)    240

TABLE 230         MEXICO: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 241

TABLE 231         MEXICO: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)       241

TABLE 232         MEXICO: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          241

9.5.4      REST OF LATIN AMERICA          242

TABLE 233         REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION) 242

TABLE 234         REST OF LATIN AMERICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 242

TABLE 235         REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          243

TABLE 236         REST OF LATIN AMERICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           243

TABLE 237         REST OF LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,  BY TYPE, 2021–2028 (USD MILLION)    244

TABLE 238         REST OF LATIN AMERICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)      244

TABLE 239         REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION)            245

TABLE 240         REST OF LATIN AMERICA: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION)      245

9.6         MIDDLE EAST & AFRICA             245

TABLE 241         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         246

TABLE 242         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    246

TABLE 243         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 247

TABLE 244         MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          247

TABLE 245         MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        248

TABLE 246         MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)       248

TABLE 247         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET,  BY TYPE, 2021–2028 (USD MILLION)      249

TABLE 248         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY,  2021–2028 (USD MILLION) 249

TABLE 249         MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY END USER,  2021–2028 (USD MILLION)         249

9.6.1      MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS            250

9.6.2      GCC      250

9.6.2.1   Focus on enhancing patient care to drive market          250

TABLE 250         GCC: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE,  2021–2028 (USD MILLION)    250

TABLE 251         GCC: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 251

TABLE 252         GCC: PATIENT SIMULATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251

TABLE 253         GCC: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     252

TABLE 254         GCC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION)          252

TABLE 255         GCC: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE,  2021–2028 (USD MILLION) 253

TABLE 256         GCC: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)          253

TABLE 257         GCC: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)          253

9.6.3      REST OF MIDDLE EAST & AFRICA           254

TABLE 258         REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)   254

TABLE 259         REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2021–2028 (USD MILLION)   254

TABLE 260         REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE,  2021–2028 (USD MILLION) 255

TABLE 261         REST OF MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  255

TABLE 262         REST OF MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET,  BY TYPE, 2021–2028 (USD MILLION) 256

TABLE 263         REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)        256

TABLE 264         REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 257

TABLE 265         REST OF MIDDLE EAST & AFRICA: HEALTHCARE SIMULATION MARKET, BY END USER, 2021–2028 (USD MILLION)         257

10          COMPETITIVE LANDSCAPE       258

10.1       INTRODUCTION            258

10.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          258

TABLE 266         KEY DEVELOPMENTS BY MAJOR PLAYERS BETWEEN JANUARY 2020 AND DECEMBER 2023         259

10.3       REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022     260

FIGURE 35         HEALTHCARE SIMULATION MARKET: REVENUE SHARE ANALYSIS OF MARKET PLAYERS             260

10.4       MARKET SHARE ANALYSIS         261

FIGURE 36         HEALTHCARE SIMULATION: MARKET SHARE ANALYSIS              261

10.5       MARKET RANKING ANALYSIS   262

FIGURE 37         HEALTHCARE SIMULATION MARKET RANKING, 2022    262

10.6       BRAND/PRODUCT COMPARATIVE ANALYSIS    263

FIGURE 38         HEALTHCARE SIMULATION: TOP TRENDING BRAND/PRODUCTS      263

10.6.1    BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT & SERVICE              264

FIGURE 39         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT & SERVICE            264

10.6.1.1 Laerdal Medical   264

10.6.1.2 CAE Inc.              264

10.6.1.3 Simulab 264

10.6.2    BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY PROVIDER COMPANY   265

FIGURE 40         BRAND/PRODUCT COMPARATIVE ANALYSIS, BY TECHNOLOGY PROVIDER COMPANY   265

10.6.2.1 Siemens Healthineers AG  265

10.6.2.2 Veradigm             265

10.6.2.3 Koninklijke Philips N.V.    266

10.7       COMPANY EVALUATION MATRIX          266

10.7.1    STARS  266

10.7.2    EMERGING LEADERS    266

10.7.3    PERVASIVE PLAYERS     267

10.7.4    PARTICIPANTS 267

FIGURE 41         HEALTHCARE SIMULATION MARKET: COMPANY EVALUATION MATRIX, 2022      267

10.7.5    COMPANY FOOTPRINT ANALYSIS         268

TABLE 267         OVERALL COMPANY FOOTPRINT (20 COMPANIES)       268

TABLE 268         COMPANY PRODUCT & SERVICE FOOTPRINT ANALYSIS (20 COMPANIES)    269

TABLE 269         COMPANY REGIONAL FOOTPRINT ANALYSIS (20 COMPANIES)              270

10.8       STARTUP/SME EVALUATION MATRIX   271

10.8.1    PROGRESSIVE COMPANIES       271

10.8.2    RESPONSIVE COMPANIES          271

10.8.3    DYNAMIC COMPANIES 271

10.8.4    STARTING BLOCKS       271

FIGURE 42         HEALTHCARE SIMULATION MARKET: STARTUP/SME EVALUATION MATRIX, 2022      272

10.8.5    COMPETITIVE BENCHMARKING            273

TABLE 270         HEALTHCARE SIMULATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES           273

TABLE 271         HEALTHCARE SIMULATION MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)  274

10.9       COMPETITIVE SCENARIO          275

10.9.1    PRODUCT LAUNCHES  275

TABLE 272         HEALTHCARE SIMULATION MARKET: PRODUCT LAUNCHES, JANUARY 2020– DECEMBER 2023             275

10.9.2    DEALS  275

TABLE 273         HEALTHCARE SIMULATION MARKET: DEALS, JANUARY 2020–DECEMBER 2023            275

10.9.3    OTHER DEVELOPMENTS           276

TABLE 274         HEALTHCARE SIMULATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020– DECEMBER 2023         276

11          COMPANY PROFILES    277

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *

11.1       KEY PLAYERS   277

11.1.1    CAE INC.            277

TABLE 275         CAE INC.: BUSINESS OVERVIEW 277

FIGURE 43         CAE INC.: COMPANY SNAPSHOT (2022) 278

11.1.2    LAERDAL MEDICAL      282

TABLE 276         LAERDAL MEDICAL: BUSINESS OVERVIEW         282

11.1.3    GAUMARD SCIENTIFIC CO.        288

TABLE 277         GAUMARD SCIENTIFIC CO.: BUSINESS OVERVIEW         288

11.1.4    KYOTO KAGAKU            299

TABLE 278         KYOTO KAGAKU: BUSINESS OVERVIEW 299

11.1.5    LIMBS & THINGS            306

TABLE 279         LIMBS & THINGS: BUSINESS OVERVIEW 306

11.1.6    MENTICE AB     311

TABLE 280         MENTICE AB: BUSINESS OVERVIEW       311

FIGURE 44         MENTICE AB: COMPANY SNAPSHOT (2022)       312

11.1.7    SIMULAB CORPORATION           316

TABLE 281         SIMULAB CORPORATION: BUSINESS OVERVIEW             316

11.1.8    SIMULAIDS       324

TABLE 282         SIMULAIDS: BUSINESS OVERVIEW         324

11.1.9    INTELLIGENT ULTRASOUND GROUP PLC         332

TABLE 283         INTELLIGENT ULTRASOUND GROUP PLC.: BUSINESS OVERVIEW        332

FIGURE 45         INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2022)          333

11.1.10  OPERATIVE EXPERIENCE INC.   336

TABLE 284         OPERATIVE EXPERIENCE INC.: BUSINESS OVERVIEW     336

11.1.11  SURGICAL SCIENCE SWEDEN AB            338

TABLE 285         SURGICAL SCIENCE SWEDEN AB: BUSINESS OVERVIEW 338

FIGURE 46         SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2022)              338

11.1.12  CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC)        341

TABLE 286         CARDIONICS INC.: BUSINESS OVERVIEW            341

11.1.13  VIRTAMED AG  342

TABLE 287         VIRTAMED AG: BUSINESS OVERVIEW    342

11.1.14  SYNBONE AG    344

TABLE 288         SYNBONE AG: BUSINESS OVERVIEW      344

11.1.15  INGMAR MEDICAL        346

TABLE 289         INGMAR MEDICAL: BUSINESS OVERVIEW          346

11.1.16  MEDICAL-X       348

TABLE 290         MEDICAL-X: BUSINESS OVERVIEW         348

11.1.17  KAVO DENTAL GMBH  351

TABLE 291         KAVO DENTAL GMBH: BUSINESS OVERVIEW     351

11.1.18  ALTAY SCIENTIFIC        352

TABLE 292         ALTAY SCIENTIFIC: BUSINESS OVERVIEW          352

11.1.19  TRUCORP LTD. 357

TABLE 293         TRUCORP LTD.: BUSINESS OVERVIEW  357

11.1.20  SIMENDO B.V.   359

TABLE 294         SIMENDO B.V.: BUSINESS OVERVIEW    359

11.2       OTHER PLAYERS           360

11.2.1    HAAG-STREIT SIMULATION GMBH       360

11.2.2    SYMGERY          360

11.2.3    HRV SIMULATION         361

11.2.4    SYNAPTIVE MEDICAL   361

11.2.5    INOVUS MEDICAL         362

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

12          APPENDIX         363

12.1       DISCUSSION GUIDE      363

12.2       CUSTOMIZATION OPTIONS      369

12.3       RELATED REPORTS       369

12.4       AUTHOR DETAILS         370